Prednisone and low-dose activated prothrombin complex concentrates for FVIII inhibitor in nonhaemophilic patients

Haemophilia

Volumn 4, Issue 5, 1998, Pages 721-724

  Ji, Linxiang ^a   Yang, Renchi ^a   Yang, Deguang ^a   Chen, Zhongkai ^a   Xing, Shuhua ^a   Tian, Mengsu ^a   Sun, Yin ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Acquired FVIII inhibitor; aPCC; Nonhaemophilia; Prednisone

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 INHIBITOR; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR V; FACTOR VIII; FACTOR XA; FEMALE; HEMOPHILIA A; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PREDNISONE; RETROSPECTIVE STUDIES;

EID: 0031706118     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1998.00184.x     Document Type: Article

References (13)

1. Green D, Lechner K. A survey of 215 non-haemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981; 45: 200-3.
2. Gatti L, Manucci PM. Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies. Thromb Haemost 1984; 51: 379-84.
3. Nilsson IM, Jonsson S, Sundqvist et al. A procedure for removing high titer antibodies by extracorporeal protein A-sepharose absorption in hemophilia. Blood 1981; 58: 38-44.
4. Hoyer LW. Acquired anticoagulants. In: Beutler E, et al., eds. Williams Hematology, 5th edn. New York: McGraw-Hill, 1995, 1486-9.
5. Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993; 70: 753-7.
6. Dibona E, Schiavoni M, Castaman G, Ciavarella N, Rodeghiero F. Acquired haemophilia: experience of two Italian centres with 17 new cases. Haemophilia 1997; 3: 183-8.
7. Sohngen D, Specker C, Bach D, et al. Acquired factor VIII inhibitors in nonhemophilic patients. Ann Hematol 1997; 74: 89-93.
8. Crenier L, Ducobu J, Grottes JD, Cerny J, Delaunoit C, Capel P. Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor. Br J Haematol 1996; 95: 750-3.
9. Lian EC-Y, Larcada AF, Chiu AY-Z. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989; 110: 774-8.
10. Hauser I, Schneider B, Lechner K. Post-partum factor VIII inhibitors: a review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995; 73: 1-5.
11. Austen DEG, Rhymes IL. A Laboratory Manual of Blood Coagulation. Blackwell Scientific Publications, Oxford, 1975, 27-54.
12. Kasper CK, Aledort LM, Counts RB, et al. A more uniform measurement of factor VIII inhibitors. Thromb Diath Haemorrh 1975; 34: 869-72.
13. Macik BG. Treatment of factor VIII inhibitors: products and strategies. Semin Thromb Hemost 1993; 19: 13-23.